Cormorant Asset Management, LP - Insider Non-Derivative Transactions at EyePoint Pharmaceuticals, Inc. (EYPT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 6, 2024, Cormorant Asset Management, LP's relationship to EyePoint Pharmaceuticals, Inc. (EYPT) is TenPercentOwner, and currently has 8,325,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other EYPT insiders.
Data Source: SEC.
Cormorant Asset Management, LP - Insider Non-Derivative Transactions of EYPT Common Stock
Cormorant Asset Management, LP - Insider Non-Derivative Transactions at EYPT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 7, 2024 | P -- (Common Stock) | 642847 | 11.7 | 8117847 |
| May 7, 2024 | P -- (Common Stock) | 207153 | 12.36 | 8325000 |
| Jan 12, 2024 | P -- (Common Stock) | 750000 | 19.75 | 6893235 |
| Jan 10, 2024 | P -- (Common Stock) | 105000 | 21.32 | 6143235 |